Articles Tagged With:
-
Researchers: Studies Cited in Court Cases on Abortion and Mental Health Impact Are Flawed
As the U.S. Supreme Court considers a case involving the abortion medication mifepristone and whether it was properly approved by the Food and Drug Administration, justices will see mention of research about abortion from flawed studies, including some that have been retracted.
-
Copper IUDs Can Be More Safely Removed by Slowing the Process
Researchers studied how to reduce the risk of breaking the intrauterine device during removal and found that slowing the removal process can help.
-
Delayed CT? ED Documentation Can Increase, or Mitigate, Risk
When CT scan delays occur, ED providers sometimes want to document in the chart all the factors beyond their control. “But trying to call out delays in the chart puts up a flag,” warns Bryan Baskin, DO, FACEP, vice chair of safety and quality at the Cleveland Clinic’s Department of Emergency Medicine and an assistant professor at Cleveland Clinic Lerner College of Medicine. Documenting objectively, such as stating, “The CT scanner was down for two hours,” is probably appropriate, he says.
-
Root Causes of Significantly Delayed CT Scans in ED Settings
EDs often experience delays obtaining computed tomography scans, with some patients waiting multiple hours for the test. This situation causes bottlenecks in patient flow, increasing length of stay and overall ED crowding.
-
Emergency Contraception Access in EDs Decreased by 96%
There are far fewer people visiting the emergency department for emergency contraception (EC) now when compared to 2006, before the Food and Drug Administration’s approval of an over-the-counter EC pill, research shows.
-
Abortion Bans Affect Sexual Assault Victims
New research shows that women who become pregnant from sexual assault are too often blocked from accessing abortion care by state laws that provide no exceptions for rape or by barriers set up in state abortion bans that do include a rape exception.
-
Permanent Contraception Skyrocketed in Period Soon After the Supreme Court Decision
New research shows a large increase in the rate of permanent contraception procedures among young women in the period from June 1, 2022, to Sept. 30, 2023 — mostly after the U.S. Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision on June 24, 2022.
-
Second Anniversary of Dobbs Decision Shows Vastly Different World for Pregnant Americans
The two years following the U.S. Supreme Court’s decision to overturn Roe v. Wade and women’s right to privacy in their most intimate healthcare decisions have created an entirely different landscape for people capable of pregnancy in America.
-
Which Is the Key Lead?
The patient whose ECG appears in the figure is a middle-aged man who presented to the emergency department with new chest pain. Should the cath lab be activated?
-
Cefepime and Enmetazobactam Injection (Exblifep)
The U.S. Food and Drug Administration has approved the combination of cefepime and enmetazobactam (FPE) for the treatment of complicated urinary tract infections. Cefepime-enmetazobactam was granted a priority review and a five-year marketing exclusivity as part of the Generating Antibiotic Incentive Now (GAIN) Act incentivizing development of new anti-infectives. FPE is distributed by Allecra Therapeutics SAS as Exblifep.